Researchers in the cancer nanomedicine community debate whether use of tiny structures, called nanoparticles, can best deliver drug therapy to tumors passively—allowing the nanoparticles to diffuse into tumors and become ...
Bio & Medicine
Mar 26, 2020
0
48
A group of scientists from NUST MISIS has presented the test results of an innovative oncotherapy technology based on hyperthermia—heating nanoparticles that have been introduced into a tumour to kill it. A drug based on ...
Bio & Medicine
Mar 12, 2020
0
32
Scientists at Washington University School of Medicine in St. Louis have developed a new imaging agent that could let doctors identify not only multiple types of tumors but the surrounding normal cells that the cancer takes ...
Cell & Microbiology
Mar 10, 2020
0
833
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue. An interdisciplinary team of researchers at Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and FU Berlin has made important progress in this ...
Bio & Medicine
Feb 24, 2020
0
2
Pancreatic cancer has one of the worst survival rates among cancers. Patients can expect as low as a 9% chance to live for at least five years after being diagnosed.
Bio & Medicine
Feb 14, 2020
0
518
Researchers from North Carolina State University have found a very high prevalence of Bartonella bacteria in tumors and tissues—but not blood samples—taken from dogs with hemangiosarcoma, a cancer of the blood vessels. ...
Plants & Animals
Jan 16, 2020
0
8
Johns Hopkins researchers report that a type of biodegradable, lab-engineered nanoparticle they fashioned can successfully deliver a "suicide gene" to pediatric brain tumor cells implanted in the brains of mice. The poly(beta-amino ...
Bio & Medicine
Jan 8, 2020
0
138
A new study at the University of Georgia has found a way to attack cancer cells that is potentially less harmful to the patient. Sodium chloride nanoparticles—more commonly known as salt—are toxic to cancer cells and ...
Bio & Medicine
Jan 8, 2020
0
335
A computational model could improve the selection of tumor antigens for personalized cancer vaccines that are now in early-stage clinical trials.
Biotechnology
Dec 17, 2019
0
20
St. Jude Children's Research Hospital scientists have identified a new therapeutic strategy that enhanced cancer immunotherapy, slowed tumor growth and extended the lives of mice with cancer. The research appears today in ...
Cell & Microbiology
Dec 12, 2019
0
370
